Literature DB >> 26200601

Monitoring Vascular Disrupting Therapy in a Rabbit Liver Tumor Model: Relationship between Tumor Perfusion Parameters at IVIM Diffusion-weighted MR Imaging and Those at Dynamic Contrast-enhanced MR Imaging.

Ijin Joo1, Jeong Min Lee1, Robert Grimm1, Joon Koo Han1, Byung Ihn Choi1.   

Abstract

PURPOSE: To investigate whether perfusion-related intravoxel incoherent motion (IVIM) diffusion-weighted (DW) magnetic resonance (MR) imaging parameters correlate with dynamic contrast material-enhanced MR imaging parameters in between-subject and/or within-subject longitudinal settings for monitoring the therapeutic effects of a vascular disrupting agent (VDA) (CKD-516) in rabbit VX2 liver tumors.
MATERIALS AND METHODS: With institutional Animal Care and Use Committee approval, 21 VX2 liver tumor-bearing rabbits (treated, n = 15; control, n = 6) underwent IVIM DW imaging with 12 b values (0-800 sec/mm(2)) and dynamic contrast-enhanced MR imaging performed before (baseline) CKD-516 administration and 4 hours, 24 hours, and 7 days after administration. Perfusion-related IVIM DW imaging parameters of the tumors, including the pseudodiffusion coefficient (D*) and perfusion fraction (f), as well as dynamic contrast-enhanced MR imaging parameters, including the volume transfer coefficient (K(trans)) and initial area under the gadolinium concentration-time curve until 60 seconds (iAUC), were measured. IVIM DW imaging parameters were correlated with dynamic contrast-enhanced MR imaging parameters by using Pearson correlation analysis between subjects at each given time and by using a linear mixed model for within-subject longitudinal data.
RESULTS: In the treated group, D*, f, K(trans), and iAUC significantly decreased (-40.7% to -26.3%) at 4-hour follow-up compared with these values in the control group (-6.9% to +5.9%) (P < .05). For longitudinal monitoring of CKD-516 treatment, D* and f showed significant positive correlations with K(trans) and iAUC (P = .004 and P = .02; P < .001 and P = .006, respectively), while no significant correlations were observed between IVIM DW imaging and dynamic contrast-enhanced MR imaging parameters between subjects at any given time (P > .05).
CONCLUSION: In a rabbit tumor model, perfusion parameters serially quantified with IVIM DW imaging can be used as alternatives to dynamic contrast-enhanced MR imaging parameters in reflecting the dynamic changes in tumor perfusion during the within-subject longitudinal monitoring of VDA treatment. © RSNA, 2015

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200601     DOI: 10.1148/radiol.2015141974

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Liver intravoxel incoherent motion (IVIM) magnetic resonance imaging: a comprehensive review of published data on normal values and applications for fibrosis and tumor evaluation.

Authors:  Yáo T Li; Jean-Pierre Cercueil; Jing Yuan; Weitian Chen; Romaric Loffroy; Yì Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2017-02

2.  Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI.

Authors:  Anish Kapadia; Hatef Mehrabian; John Conklin; Sean P Symons; Pejman J Maralani; Greg J Stanisz; Arjun Sahgal; Hany Soliman; Chinthaka C Heyn
Journal:  J Neurooncol       Date:  2017-07-01       Impact factor: 4.130

Review 3.  Diffusion-weighted MRI of the liver: challenges and some solutions for the quantification of apparent diffusion coefficient and intravoxel incoherent motion.

Authors:  Yi Xiang J Wang; Hua Huang; Cun-Jing Zheng; Ben-Heng Xiao; Olivier Chevallier; Wei Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

Review 4.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

5.  Longitudinal Correlations Between Intravoxel Incoherent Motion (IVIM) and Dynamic Contrast-Enhanced (DCE) MRI During Radiotherapy in Prostate Cancer Patients.

Authors:  Ernst S Kooreman; Vivian van Pelt; Marlies E Nowee; Floris Pos; Uulke A van der Heide; Petra J van Houdt
Journal:  Front Oncol       Date:  2022-06-07       Impact factor: 5.738

6.  Dose-response assessment by quantitative MRI in a phase 1 clinical study of the anti-cancer vascular disrupting agent crolibulin.

Authors:  Andres M Arias Lorza; Harshan Ravi; Rohit C Philip; Jean-Philippe Galons; Theodore P Trouard; Nestor A Parra; Daniel D Von Hoff; William L Read; Raoul Tibes; Ronald L Korn; Natarajan Raghunand
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379

Review 7.  Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors.

Authors:  Li Liu; Devin O'Kelly; Regan Schuetze; Graham Carlson; Heling Zhou; Mary Lynn Trawick; Kevin G Pinney; Ralph P Mason
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

8.  Application values of 3.0T magnetic resonance diffusion weighted imaging for distinguishing liver malignant tumors and benign lesions.

Authors:  Ruibin Li; Guangyao Wu; Rui Wang
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

9.  Evaluation of Regional Variability and Measurement Reproducibility of Intravoxel Incoherent Motion Diffusion Weighted Imaging Using a Cardiac Stationary Phase Based ECG Trigger Method.

Authors:  Zhiming Xiang; Zhu Ai; Jianke Liang; Guijin Li; Xiaolei Zhu; Xu Yan
Journal:  Biomed Res Int       Date:  2018-04-17       Impact factor: 3.411

10.  MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.

Authors:  Jun Yang; Chengde Liao; Yifan Liu; Guangjun Yang; Tengfei Ke; Yingying Ding; Qinqing Li
Journal:  Oncotarget       Date:  2017-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.